Your browser doesn't support javascript.
loading
The Impact of Pre-existing Comorbidities and Therapeutic Interventions on COVID-19.
Callender, Lauren A; Curran, Michelle; Bates, Stephanie M; Mairesse, Maelle; Weigandt, Julia; Betts, Catherine J.
Affiliation
  • Callender LA; Immunotoxicology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, United Kingdom.
  • Curran M; Department of Surgery, University of Cambridge, NIHR Cambridge Biomedical, Cambridge, United Kingdom.
  • Bates SM; Immunotoxicology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, United Kingdom.
  • Mairesse M; Department of Surgery, University of Cambridge, NIHR Cambridge Biomedical, Cambridge, United Kingdom.
  • Weigandt J; Immunotoxicology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, United Kingdom.
  • Betts CJ; Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom.
Front Immunol ; 11: 1991, 2020.
Article in En | MEDLINE | ID: mdl-32903476
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia, Viral / Comorbidity / Coronavirus Infections Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Front Immunol Year: 2020 Document type: Article Affiliation country: Reino Unido Country of publication: Suiza
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia, Viral / Comorbidity / Coronavirus Infections Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Front Immunol Year: 2020 Document type: Article Affiliation country: Reino Unido Country of publication: Suiza